These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25045214)

  • 1. Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation.
    Chen X; Zeng S; Zou J; Chen Y; Yue Z; Gao Y; Zhang L; Cao W; Liu P
    Mediators Inflamm; 2014; 2014():868753. PubMed ID: 25045214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
    Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
    Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
    Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
    J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
    Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
    Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of Astragalus polysaccharides against endothelial dysfunction in hypertrophic rats induced by isoproterenol.
    Han R; Tang F; Lu M; Xu C; Hu J; Mei M; Wang H
    Int Immunopharmacol; 2016 Sep; 38():306-12. PubMed ID: 27344039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
    Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
    Planavila A; Laguna JC; Vázquez-Carrera M
    J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR.
    Liu R; Zhang HB; Yang J; Wang JR; Liu JX; Li CL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7500-7508. PubMed ID: 30468499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.
    Li Y; Shen D; Tang X; Li X; Wo D; Yan H; Song R; Feng J; Li P; Zhang J; Li J
    Toxicol Lett; 2014 May; 226(3):257-63. PubMed ID: 24583048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
    Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
    Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
    Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
    Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinase Inhibitor Auranofin Attenuated Cardiac Hypertrophy by Blocking NF-κB Activation.
    Hu M; Zhang Z; Liu B; Zhang S; Chai R; Chen X; Kong T; Zhang F; Zhang J; Liu S; Liu N
    Cell Physiol Biochem; 2018; 45(6):2421-2430. PubMed ID: 29554646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.